The increased levels of miR-96 in both the tumor tissue and serum of lung cancer patients, along with the decreased level of LMO7 in tumor tissue, support the notion that miR-96 may play a tumor-promoting role in lung cancer. This evidence concerns the gene LMO7 and neoplasm.